This book aims to address the major aspects of future drug product development and therapy for older adults, giving practical guidance for the rational product and clinical development and prescribing of drug products to older patients. The book wil provide valuable information for students, scientists, regulators, practitioners and industry. Sven Stegeman is the editor of the book entitled Developing Drug Products in an Aging Society. Paul Jansen from Ephor has contributed with a chapter to the book. The costs of the e-book are 190,39 euro and hard-cover 242,74 euro. Publisher Springer, ISBN 978-3-319-43097-3.